Pharma AI|10 Mar 2026
Regolo research finds 75% of EU businesses expose customer data to foreign surveillance.
The Story
This highlights a significant vulnerability in data handling practices across European companies.
Why It Matters
This isn't just a headline; it's a ticking clock for regulated EU pharma. Your data, your patients' data, is likely at risk. The upcoming EU AI Act isn't just about AI models; it's about the entire data lifecycle. Ignoring this now means compliance headaches later.
What To Do About It
I can audit your current data architecture and identify foreign exposure risks, preparing you for EU AI Act compliance and securing your valuable pharma data.
small pharma AIlife sciences SMB AIpharma data privacy AIbiotech startup AI compliancepharma SME AI
